chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 70 yo male with PMH of cirrhosis of liver, gallstone, neurocognitive disorder, angina, shoulder pain, depression, calcification of spleen, sleep apnea, CKD stage 3, OA, HF with reduced EF 20-25%, diabetes, diabetic peripheral neuropathy, and CAD passed away on 4/7/2021 under hospice care. Pt received the vaccine (while under hospice care) on 3/30/21, second dose of Moderna. He received first dose on 3/4/2021. Both doses were administered without complications. Most recent hospitalization is from 3/3-3/18/21 at the medical center for acute on chronic CHF exacerbation. He was sent to the nursing home after the hospitalization and was discharged to a community nursing home on 3/31/021. Pt passed away on 4/7/2021 at the community nursing home.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Anticoagulant therapy, Deep vein thrombosis, Peripheral swelling, Platelet count normal
Clinical narrative: Narrative: Patient is a 74 year-old male who received his first COVID vaccine on 2/16 and his second dose on 3/11. On 4/19, patient presented to the emergency department with lower extremity swelling, and was found to have bilateral LE DVTs. He was started on apixaban (started with VTE initiation dose) for his event. Per our ID pharmacy evaluation: Vaccine induced thrombosis has been shown to be associated with the Johnson and Johnson vaccine (and Astrazeneca though this is not available for use in this country) which is an adenovirus vaccine. VIT typically occurs within 30 days of vaccine receipt and is often accompanied by low platelets. This association between vaccine and thrombosis has not been shown with the MRNA vaccine (Pfizer or Moderna). It is unlikely that DVT is 2/2 COVID vaccine. Patient received MRNA vaccine which has not been shown to be associated with VIT. Additionally PLTS are wnl and patient has other risk factors for thrombosis such as obesity (BMI ~34), paraplegia (decreased mobility), history of prior thrombosis, and history of cancer. Event is being reported as an ADR given it was within 6 weeks of the vaccine administration.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Fatigue, Lip swelling, Nausea
Clinical narrative: Narrative: Patient received COVID -19 vaccine (Moderna) first dose 1/29/2021. Three to four hours after dose, she had tongue and lip swelling and arm swelling. Had fatigue, loss appetite, N/D. Sx improved after Benadryl 25mg PO.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Swollen tongue
Clinical narrative: Narrative: Patient received COVID -19 vaccine (Moderna) first dose 1/29/2021. Three to four hours after dose, she had tongue and lip swelling and arm swelling. Had fatigue, loss appetite, N/D. Sx improved after Benadryl 25mg PO.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. The Patient was not receiving regular care through the health system. Patient was a 90 yo, has PMH significant for hypertension, T2DM, Sleep Apnea, Hyperlipidemia, H/O DVT and PE. No documentation in chart for Cause of Death.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH Significant for T2DM, arteriosclerosis of coronary bypass graft, AF, cardiac arrhythmia, sleep apnea, diastolic dysfunction, cerebrovascular accident, hyperlipidemia, HTN. No recent hospitalizations or illness documented. Patient deceased 5/09 with no information regarding death noted. Pt was 69 years of age
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative: no severity in event. N/A. note was signed on incorrect appointment date.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, No adverse event
Clinical narrative: Narrative: no reaction reported. vaccine incorrectly documented, wrong manufacturer charted. Documentation corrected
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Death, Dyspnoea, Dyspnoea exertional, Dyspnoea paroxysmal nocturnal
Clinical narrative: Narrative:  62 yo male with PMH of COPD, not on home oxygen, HFpEF, chronic IDA, HTN, hep C, hx of prostate CA s/p radical prostatectomy, was found dead in his home on 04/23/2021. Prior to his death, patient left AMA on 4/19/2021. Pt was admitted on 4/18/2021 for shortness of breath/acute on chronic hypoxic respiratory failure. Per discharge summary on 4/19/21, patient had increasing SOB for past 2 weeks, unable to walk 10 feet without become SOB. He was found to have orthopnea, PND, and bilateral pedal edema. Records also showed that patinet left AMA on 3/30/21 at the ED. It was recommended that he went to ED due to low hemoglobin of 7.2 (trending downward).
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Oedema peripheral, Orthopnoea, Respiratory failure
Clinical narrative: Narrative:  62 yo male with PMH of COPD, not on home oxygen, HFpEF, chronic IDA, HTN, hep C, hx of prostate CA s/p radical prostatectomy, was found dead in his home on 04/23/2021. Prior to his death, patient left AMA on 4/19/2021. Pt was admitted on 4/18/2021 for shortness of breath/acute on chronic hypoxic respiratory failure. Per discharge summary on 4/19/21, patient had increasing SOB for past 2 weeks, unable to walk 10 feet without become SOB. He was found to have orthopnea, PND, and bilateral pedal edema. Records also showed that patinet left AMA on 3/30/21 at the ED. It was recommended that he went to ED due to low hemoglobin of 7.2 (trending downward).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial flutter, Cardiac failure, Death, Intensive care
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was brought to the ED on 3/15/21 and transferred to another hospital MICU for decompensated heart failure and atrial flutter in the setting of severe mitral stenosis suffering with acute hypoxic respiratory failure. Attending predicted with patient's severe mitral stenosis he did not have but 1-2 months of life left. He was transitioned to palliative care and transferred to inpatient hospice on 3/23/21 where he passed away on 4/5/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Life expectancy shortened, Mitral valve stenosis
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was brought to the ED on 3/15/21 and transferred to another hospital MICU for decompensated heart failure and atrial flutter in the setting of severe mitral stenosis suffering with acute hypoxic respiratory failure. Attending predicted with patient's severe mitral stenosis he did not have but 1-2 months of life left. He was transitioned to palliative care and transferred to inpatient hospice on 3/23/21 where he passed away on 4/5/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atrial fibrillation, COVID-19, Chest X-ray abnormal, Cough
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 01/25 COVID Vaccine dose #1 02/16 COVID vaccine dose #2 04/18 Admitted to outside hospital c/o SOB and weakness, o2 sat 92% on RA, tachypneic and in afib with RVR upon arrival to ED; CXR showed diffuse infiltrates. COVID test was positive; HR improved after fluid bolus; started on remdesivir and dexamethasone through 4/22 04/22 discharged from outside hospital on home oxygen 04/27 Only persistent symptom is intermittent cough
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Lung infiltration, SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 01/25 COVID Vaccine dose #1 02/16 COVID vaccine dose #2 04/18 Admitted to outside hospital c/o SOB and weakness, o2 sat 92% on RA, tachypneic and in afib with RVR upon arrival to ED; CXR showed diffuse infiltrates. COVID test was positive; HR improved after fluid bolus; started on remdesivir and dexamethasone through 4/22 04/22 discharged from outside hospital on home oxygen 04/27 Only persistent symptom is intermittent cough
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Influenza
Clinical narrative: Narrative:  Dose 1 Moderna: Days 2 & 3--Slight diarrhea with some chills. Left arm soreness. Tired, headache and diarrhea. After 1 week, fsore throat, headache, diarrhea, flu symptoms, chest congestion. No symptoms after three weeks.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity, Respiratory tract congestion
Clinical narrative: Narrative:  Dose 1 Moderna: Days 2 & 3--Slight diarrhea with some chills. Left arm soreness. Tired, headache and diarrhea. After 1 week, fsore throat, headache, diarrhea, flu symptoms, chest congestion. No symptoms after three weeks.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Diarrhoea, Dizziness, Nausea, SARS-CoV-2 test negative
Clinical narrative: Narrative:  He relates having developed nausea, diarrhea and cold sweats the day after the initial vaccination - which lasted for about 10 days afterwards. Towards the end of the 10 days, he also experienced mild dizziness and the nausea occasionally persists. He took OTC pepto-bismol, which did not provide ver much relief. During the He spoke with his provider, who informed him that "She thinks I may have been exposed to COVID in the past causing the symptoms from the first dose." Last COVID testing done in June/July was negative and he has no new medications (OTC or rx) or known exposure.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative:  Patient seen checking own pulse said he felt lightheaded and dizzy possibly low blood pressure, he was given water and juice symptoms alleviated on their won, he was monitored for additional 15 mins and left clinic without any further complaints
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  COVID infection requiring hospitalization in a fully vaccinated individual
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, Blood sodium normal, COVID-19, Cardiomegaly, Chest X-ray abnormal
Clinical narrative: None stated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Cyst, Electrocardiogram abnormal, Fibrin D dimer, Lung consolidation
Clinical narrative: None stated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Lung disorder, Pleural effusion, Pneumonia, Pulmonary embolism, Pulmonary fibrosis
Clinical narrative: None stated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary infarction, SARS-CoV-2 antibody test, SARS-CoV-2 test, SARS-CoV-2 test positive, Thrombosis
Clinical narrative: None stated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I normal
Clinical narrative: None stated.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Influenza like illness, Pain, Pyrexia
Clinical narrative: Narrative:  At her appointment for her second dose on 5/4/21, patient reported that she had a fever of 102 degrees 5 days after receiving the 1st COVID vaccine dose on 4/13/21, along with chills and aching of body, "like flu". Was tested for Covid and was negative. Managed symptoms with Tylenol with some relief of fever. After 48 hours fever subsided, was still weak for a few days.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: Narrative:  At her appointment for her second dose on 5/4/21, patient reported that she had a fever of 102 degrees 5 days after receiving the 1st COVID vaccine dose on 4/13/21, along with chills and aching of body, "like flu". Was tested for Covid and was negative. Managed symptoms with Tylenol with some relief of fever. After 48 hours fever subsided, was still weak for a few days.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Magnetic resonance imaging head normal, Nasal congestion, Paranasal cyst
Clinical narrative: Narrative:  Patient received first dose of COVID-19 (Moderna) vaccine on 03/30/21. Had f/u with Dr. on 05/04 where patient reported that he started having headaches 5 days after his Moderna vaccine. Endorses constant headache through all hours of the day. APAP and ASA provide no relief. Dr. recommend MRI of the brain. Results have come back, no acute processes found. Pending further w/u for sinus congestion and mucoid sinus cysts. Patient has been referred to ENT.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cancer, Chemotherapy, Deep vein thrombosis, Thrombocytopenia
Clinical narrative: Narrative:  Patient experienced RLE DVT within3 weeks of receiving the Janssen COVID-19 vaccine. Patient also with thrombocytopenia at time of diagnosis. Of note patient with bladder carcinoma on chemo. DVT possibly cancer associated vs vaccine-related and the thrombocytopenia is common with chemo (gemcitabine + carboplatin). Patient was started on apixaban therapy for DVT.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Exposure to communicable disease, Myalgia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series completion 01/04 COVID vaccine dose #1 01/25 COVID vaccine dose #2 04/26 pt tested for covid due to symptoms of loss of taste (smell intact), myalgia since "last wednesday,"reports close contact with someone with respiratory illness; tested positive
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Condition aggravated, Death, Dehydration, Diuretic therapy
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was previously discharged on 3/1/21 for a heart failure exacerbation with edema. He came back to the ED on 4/10/21 with general weakness, dehydration, and shortness of breath. His admission consisted of persistent hypotension which limited the ability for diuresis for his edema. His mental status declined and he was transition to hospice care before passing on 4/17/21. PMH significant for CAD/atherosclerosis, STEMI, hypertension, diabetes, hyperlipidemia, AAA s/p open repair 2008, aortic arch aneurysm has declined surgical repair, COPD, tobacco abuse, alcohol abuse, CVA, cerebral aneurysm.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypotension, Mental status changes, Oedema
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was previously discharged on 3/1/21 for a heart failure exacerbation with edema. He came back to the ED on 4/10/21 with general weakness, dehydration, and shortness of breath. His admission consisted of persistent hypotension which limited the ability for diuresis for his edema. His mental status declined and he was transition to hospice care before passing on 4/17/21. PMH significant for CAD/atherosclerosis, STEMI, hypertension, diabetes, hyperlipidemia, AAA s/p open repair 2008, aortic arch aneurysm has declined surgical repair, COPD, tobacco abuse, alcohol abuse, CVA, cerebral aneurysm.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: Narrative: He relates having experienced nausea and myalgia that started about 2 hours after the initial vaccination. This lasted for about an hour and resolved  with rest. No therapies or tried or applied. He did not experience other common adverse effects including vomiting, abdominal cramping, and diarrhea. During the  episode, he was able to tolerate oral intake.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative: Timing error only. No ADR. Vet received 2nd  dose days after 1st dose due to scheduling error.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscle twitching
Clinical narrative: Narrative: Pt. stated that he had on and off left forehead twitching that causes headache for 10 days which started on the day he received  his first dose.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Causality of death is unknown. Report is of timing of vaccination 2/5/21 to death 3/3/21
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Feeling abnormal, Headache
Clinical narrative: Narrative:  Patient contacted telephone triage nurse today requesting appt with provider. Patient states he had his second covid vaccine on 4/20/2021, "And I still feel horrible." Patient is c/o intermittent headaches (none today), sinus pressure/congestion, "clear drainage", cough/chest congestion, "Mainly clear phlegm, but don't look." +Sore throat, fatigue, body aches. Some increased wheezing - pmh: COPD, using inhaler as directed, "helps." No chest pain with cough or deep inspiration. +Intermittent chills. No leg swelling. Patient also coincidentally mentions "both hands are mildly swollen the past 10 days, since I received the vaccine." Urinating well, "I'm staying hydrated, urinating fine, urine looks normal." No facial or abdominal swelling. spO2 = 96% room air. B/P: 142/98, pulse 91. Temp 97.3. Patient's biggest concern is fatigue, "I just feel so worn out, not getting better." Patient is interested in obtaining a covid test today, number has been provided - states he will call now.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Paranasal sinus discomfort, Peripheral swelling, Respiratory tract congestion
Clinical narrative: Narrative:  Patient contacted telephone triage nurse today requesting appt with provider. Patient states he had his second covid vaccine on 4/20/2021, "And I still feel horrible." Patient is c/o intermittent headaches (none today), sinus pressure/congestion, "clear drainage", cough/chest congestion, "Mainly clear phlegm, but don't look." +Sore throat, fatigue, body aches. Some increased wheezing - pmh: COPD, using inhaler as directed, "helps." No chest pain with cough or deep inspiration. +Intermittent chills. No leg swelling. Patient also coincidentally mentions "both hands are mildly swollen the past 10 days, since I received the vaccine." Urinating well, "I'm staying hydrated, urinating fine, urine looks normal." No facial or abdominal swelling. spO2 = 96% room air. B/P: 142/98, pulse 91. Temp 97.3. Patient's biggest concern is fatigue, "I just feel so worn out, not getting better." Patient is interested in obtaining a covid test today, number has been provided - states he will call now.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus congestion, Wheezing
Clinical narrative: Narrative:  Patient contacted telephone triage nurse today requesting appt with provider. Patient states he had his second covid vaccine on 4/20/2021, "And I still feel horrible." Patient is c/o intermittent headaches (none today), sinus pressure/congestion, "clear drainage", cough/chest congestion, "Mainly clear phlegm, but don't look." +Sore throat, fatigue, body aches. Some increased wheezing - pmh: COPD, using inhaler as directed, "helps." No chest pain with cough or deep inspiration. +Intermittent chills. No leg swelling. Patient also coincidentally mentions "both hands are mildly swollen the past 10 days, since I received the vaccine." Urinating well, "I'm staying hydrated, urinating fine, urine looks normal." No facial or abdominal swelling. spO2 = 96% room air. B/P: 142/98, pulse 91. Temp 97.3. Patient's biggest concern is fatigue, "I just feel so worn out, not getting better." Patient is interested in obtaining a covid test today, number has been provided - states he will call now.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:  Dose #1 The patient received Moderna COVID-19 Vaccine 0.5 ml IM. MVX (Manuf); Lot#; Exp Date: MOD; 012A21A; 08/17/2021 Administration Anatomic site: Right Deltoid
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Carotid artery stenosis, Death, Hyperlipidaemia, Hypertension, Pain
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient suffered a stroke in January 2015 and has still suffered the residual effects including weakness and dysphagia. Patient's wife requested hospice care due to patient's considerable pain keeping him up all night and her inability to care for him any longer. Palliative care consult placed on 2/18/21 and he passed away on 3/9/21.  Patient had advanced age, carotid artery stenosis, chronic pain, HTN, HLD
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient suffered a stroke in January 2015 and has still suffered the residual effects including weakness and dysphagia. Patient's wife requested hospice care due to patient's considerable pain keeping him up all night and her inability to care for him any longer. Palliative care consult placed on 2/18/21 and he passed away on 3/9/21.  Patient had advanced age, carotid artery stenosis, chronic pain, HTN, HLD
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  COVID infection requiring hospitalization in fully vaccinated individual
Age: 32.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site oedema, Injection site pain, Injection site warmth, Skin oedema
Clinical narrative: Narrative:  Patient presented to primary care clinic with complaints of warm, tender, painful arm where he had received the flu shot the previous day. Skin around injection site was slightly edematous, warm and painful. Patient was evaluated by a nurse and provider ordered prednisone dose-pack and Augmentin. Symptoms resolved and required no further care.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:  The developed the same day as the vaccination and lasted for about 2 days prior to spontaneously resolving without intervention. He denied other common adverse effects including nausea, vomiting, and diarrhea.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy lymph gland, Bronchoscopy abnormal, Cerebrovascular accident, Chest pain, Condition aggravated
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factor (PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for cerebral infarction, Diabetes type 2, hyperlipidemia, tobacco use, COPD, kidney cyst, thyroid nodule. squamous cell carcinoma, right lung mass. Per note 4/19 "A PET scan showed a large, centrally necrotic right apical lung mass extending into the right hilum as well as invading the posterior right upper lobe proximal airways and right pleura. He underwent bronchoscopy with FNA of a lymph node on 3/30/21. The official pathology report on this is still pending the results of immunostains. He was also incidentally found to have evidence of a subacute CVA on MRI of the brain. He left AMA at that time. He returned to the ED on 4/13/21 to pursue additional workup of his lung mass and reported ongoing chest pain. He was then transferred to the hospital for ongoing care. The patient's chest pain, deemed to be pleuritic in the setting of lung tumor and post-obstructive pneumonia, has been controlled with Norco prn. He exhibited clinical signs of pneumonia, and was started on antibiotic therapy. He was initially on doxycycline and ceftriaxone, but he was switched to vancomycin/cefepime/Flagyl on 4/18/21 when his white count continued to rise" Patient deceased 4/25 but not notation of cause of death documented.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Lung neoplasm, Magnetic resonance imaging head abnormal, Pathology test, Pleural mass
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factor (PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for cerebral infarction, Diabetes type 2, hyperlipidemia, tobacco use, COPD, kidney cyst, thyroid nodule. squamous cell carcinoma, right lung mass. Per note 4/19 "A PET scan showed a large, centrally necrotic right apical lung mass extending into the right hilum as well as invading the posterior right upper lobe proximal airways and right pleura. He underwent bronchoscopy with FNA of a lymph node on 3/30/21. The official pathology report on this is still pending the results of immunostains. He was also incidentally found to have evidence of a subacute CVA on MRI of the brain. He left AMA at that time. He returned to the ED on 4/13/21 to pursue additional workup of his lung mass and reported ongoing chest pain. He was then transferred to the hospital for ongoing care. The patient's chest pain, deemed to be pleuritic in the setting of lung tumor and post-obstructive pneumonia, has been controlled with Norco prn. He exhibited clinical signs of pneumonia, and was started on antibiotic therapy. He was initially on doxycycline and ceftriaxone, but he was switched to vancomycin/cefepime/Flagyl on 4/18/21 when his white count continued to rise" Patient deceased 4/25 but not notation of cause of death documented.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pleuritic pain, Pneumonia, Positron emission tomogram abnormal, Pulmonary hilum mass, Pulmonary mass
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factor (PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for cerebral infarction, Diabetes type 2, hyperlipidemia, tobacco use, COPD, kidney cyst, thyroid nodule. squamous cell carcinoma, right lung mass. Per note 4/19 "A PET scan showed a large, centrally necrotic right apical lung mass extending into the right hilum as well as invading the posterior right upper lobe proximal airways and right pleura. He underwent bronchoscopy with FNA of a lymph node on 3/30/21. The official pathology report on this is still pending the results of immunostains. He was also incidentally found to have evidence of a subacute CVA on MRI of the brain. He left AMA at that time. He returned to the ED on 4/13/21 to pursue additional workup of his lung mass and reported ongoing chest pain. He was then transferred to the hospital for ongoing care. The patient's chest pain, deemed to be pleuritic in the setting of lung tumor and post-obstructive pneumonia, has been controlled with Norco prn. He exhibited clinical signs of pneumonia, and was started on antibiotic therapy. He was initially on doxycycline and ceftriaxone, but he was switched to vancomycin/cefepime/Flagyl on 4/18/21 when his white count continued to rise" Patient deceased 4/25 but not notation of cause of death documented.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary necrosis, White blood cell count increased
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factor (PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for cerebral infarction, Diabetes type 2, hyperlipidemia, tobacco use, COPD, kidney cyst, thyroid nodule. squamous cell carcinoma, right lung mass. Per note 4/19 "A PET scan showed a large, centrally necrotic right apical lung mass extending into the right hilum as well as invading the posterior right upper lobe proximal airways and right pleura. He underwent bronchoscopy with FNA of a lymph node on 3/30/21. The official pathology report on this is still pending the results of immunostains. He was also incidentally found to have evidence of a subacute CVA on MRI of the brain. He left AMA at that time. He returned to the ED on 4/13/21 to pursue additional workup of his lung mass and reported ongoing chest pain. He was then transferred to the hospital for ongoing care. The patient's chest pain, deemed to be pleuritic in the setting of lung tumor and post-obstructive pneumonia, has been controlled with Norco prn. He exhibited clinical signs of pneumonia, and was started on antibiotic therapy. He was initially on doxycycline and ceftriaxone, but he was switched to vancomycin/cefepime/Flagyl on 4/18/21 when his white count continued to rise" Patient deceased 4/25 but not notation of cause of death documented.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient received 2nd dose of moderna 2/10/2021. Patient has PMH significant for malignant tumor of urinary bladder, Ischemic heart death, t2dm, AF. Patient passed away on 3/19/2021 under hospice care.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Gout
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 95 and received care in the ED on 3/9/21 for a gout flare. No notes documenting his death on 3/25/21 are in his chart records. Comorbidities include advanced age, afib, mechanical mitral valve replacement, chronic renal failure, CAD, HTN.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea exertional, Fatigue, Myalgia
Clinical narrative: Narrative: Patient with myalgias, chills, fatigue and dyspnea on exertion following vaccine administration. Symptoms persistent 4-5 days after vaccine administration in patient with known CAD so presented for further evaluation as an inpatient.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Narrative: pt has unresolved joint pain after his second  covid vaccination (Moderna) in spite of RICE/medications.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. ON 3/19/21 Patient had a CT that showed a possible malignancy of lung cancer with possible liver metastases. He went to the ED on 3/25/21 with severe abdominal pain and later passed away that day. Care was outside of clinic, so unable to determine diagnosis or suspected cause of death. Comorbidities include CHF, afib, COPD, smoker, anemia, HTN, HLD, PTSD.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood albumin normal, Blood alkaline phosphatase normal, Blood calcium normal
Clinical narrative: Narrative:  County Coroner called to say that patient passed on 3/20/21 from suspected stroke at home while asleep. Telephone if there are any questions. Due to patient receiving COVID-19 Vaccine dose #1 on 2/12/2021 and dose #2 on 3/20/2021 reporting as possible vaccine reaction.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood chloride normal, Blood cholesterol, Blood creatinine normal, Blood potassium normal, Blood sodium normal
Clinical narrative: Narrative:  County Coroner called to say that patient passed on 3/20/21 from suspected stroke at home while asleep. Telephone if there are any questions. Due to patient receiving COVID-19 Vaccine dose #1 on 2/12/2021 and dose #2 on 3/20/2021 reporting as possible vaccine reaction.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood triglycerides, Blood urea increased, Carbon dioxide normal, Cerebrovascular accident, Death
Clinical narrative: Narrative:  County Coroner called to say that patient passed on 3/20/21 from suspected stroke at home while asleep. Telephone if there are any questions. Due to patient receiving COVID-19 Vaccine dose #1 on 2/12/2021 and dose #2 on 3/20/2021 reporting as possible vaccine reaction.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, High density lipoprotein, International normalised ratio increased, Low density lipoprotein
Clinical narrative: Narrative:  County Coroner called to say that patient passed on 3/20/21 from suspected stroke at home while asleep. Telephone if there are any questions. Due to patient receiving COVID-19 Vaccine dose #1 on 2/12/2021 and dose #2 on 3/20/2021 reporting as possible vaccine reaction.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Platelet count normal, Protein total normal, Prothrombin time prolonged, White blood cell count normal
Clinical narrative: Narrative:  County Coroner called to say that patient passed on 3/20/21 from suspected stroke at home while asleep. Telephone if there are any questions. Due to patient receiving COVID-19 Vaccine dose #1 on 2/12/2021 and dose #2 on 3/20/2021 reporting as possible vaccine reaction.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site swelling, Nausea, Pain
Clinical narrative: Narrative: Veteran contacted telephone triage requesting appt with provider for c/o nausea and body aches since receiving his 2nd covid vaccination 2 days ago.  Veteran states "I had similar reaction after I got the first vaccine but it's worse now. I just ache all over and I'm having nausea on and off. Plus the spot where I got the injection is a little swollen too." He denies feeling feverish, coughing or  difficulty breathing. Please advise, thank you. Class Code: Other specified counseling. Patient/Caller agrees with plan. **Veteran was notified that this visit may include telephone and/or virtual video care appointment. VCC: Veteran does not qualify for VCC due to inability to connect, personal preference, no email address, or no VCC provider available. Caller/Veteran advised to call facilities  VA Clinical Advice Call Center or seek immediate medical attention for new or worsening symptoms.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cancer, Death, Gastric cancer, Oesophageal carcinoma
Clinical narrative: Narrative: reporting due to pt recieving covid 19 vaccine within 42 days of death. pt placed on hospice care -pt had for end stage esophageal, gastric, and bladder cancers
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Peripheral ischaemia
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PT has a PMH significant for solitary nodule of lung, CVA due to cerebral artery occlusion, tobacco use, mitral valve disorder, hyperlipidemia, chronic obstructive lung disease. Patient presented to outside entity emergency facility on 3/22 with a chief complaint of "ACUTE LIMB ISCHEMIA". Pt passed away 4/6/21.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 95 and not receiving regular care in the facility. Last PCP appointment was 2 years prior. He passed away on 3/29/21 with no documented details regarding his possible cause of death. Potential contributing comorbidities include advanced age, CKD, HLD, HTN, CAD, myelodysplastic disease
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory distress syndrome, Aortic occlusion, CT hypotension complex, Cardiac ventricular thrombosis
Clinical narrative: Narrative:  Cause of death bilateral PE, however patient has other potential causes of PE: amputee Reported as a possible cause/catalyst of PE resulting in death.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiomegaly, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Condition aggravated, Death
Clinical narrative: Narrative:  Cause of death bilateral PE, however patient has other potential causes of PE: amputee Reported as a possible cause/catalyst of PE resulting in death.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram, Gastrointestinal oedema, Intra-abdominal fluid collection, Ischaemic hepatitis
Clinical narrative: Narrative:  Cause of death bilateral PE, however patient has other potential causes of PE: amputee Reported as a possible cause/catalyst of PE resulting in death.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Pelvic venous thrombosis, Perinephric oedema, Pleural effusion, Pulmonary embolism
Clinical narrative: Narrative:  Cause of death bilateral PE, however patient has other potential causes of PE: amputee Reported as a possible cause/catalyst of PE resulting in death.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary oedema, Vena cava thrombosis, Ventricular dysfunction, Ventricular septal defect
Clinical narrative: Narrative:  Cause of death bilateral PE, however patient has other potential causes of PE: amputee Reported as a possible cause/catalyst of PE resulting in death.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient received both doses of pfizer at outside entity as a nursing home resident.. Patient has PMH significant for advanced age, dementia, CHF, AF.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure, Death, Dyspnoea, Oedema peripheral
Clinical narrative: Narrative:  Patient was previously COVID-19 positive in December 2020, but did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to the ED on 3/1/21 for a new onset heart failure diagnosis presenting with shortness of breath and bilateral lower leg edema. Patient was discharged on 3/3/21 with a request to received palliative care. He passed away on 3/21/21 with details surrounding his passing unclear and not documented in his chart. Comorbidities included COPD, smoker, chronic pain syndrome on chronic opioids with benzodiazepines, obesity, HTN
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Abulia, COVID-19, Comminuted fracture, Death, Encephalopathy
Clinical narrative: Narrative: The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt received 2nd dose Pfizer on 2/09/2021. Pt tested positive for covid on 3/26/2021. PT has a PMH significant for CHF, AF, smoker's cough, COPD, PVD, HTN. Per note ....."He presented to the ED on 3/26/21 after a mechanical fall. X-rays showed a comminuted right hip fracture. He was also found to be COVID positive on 3/26, although he has received doses of the COVID vaccine 1/20 and 2/9. He initially was oriented but has been acutely encephalopathic and unable to make decisions. He has been diagnosed with bacterial/aspiration PNA. He was receiving antibiotics initially. His daughters decided after multiple discussions about his poor prognosis to pursue comfort care including hospice placement and no surgery. They also asked for comfort feeds and to discontinue antibiotics. "
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hip fracture, Pneumonia aspiration, Pneumonia bacterial, SARS-CoV-2 test positive
Clinical narrative: Narrative: The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt received 2nd dose Pfizer on 2/09/2021. Pt tested positive for covid on 3/26/2021. PT has a PMH significant for CHF, AF, smoker's cough, COPD, PVD, HTN. Per note ....."He presented to the ED on 3/26/21 after a mechanical fall. X-rays showed a comminuted right hip fracture. He was also found to be COVID positive on 3/26, although he has received doses of the COVID vaccine 1/20 and 2/9. He initially was oriented but has been acutely encephalopathic and unable to make decisions. He has been diagnosed with bacterial/aspiration PNA. He was receiving antibiotics initially. His daughters decided after multiple discussions about his poor prognosis to pursue comfort care including hospice placement and no surgery. They also asked for comfort feeds and to discontinue antibiotics. "
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray abnormal
Clinical narrative: Narrative: The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt received 2nd dose Pfizer on 2/09/2021. Pt tested positive for covid on 3/26/2021. PT has a PMH significant for CHF, AF, smoker's cough, COPD, PVD, HTN. Per note ....."He presented to the ED on 3/26/21 after a mechanical fall. X-rays showed a comminuted right hip fracture. He was also found to be COVID positive on 3/26, although he has received doses of the COVID vaccine 1/20 and 2/9. He initially was oriented but has been acutely encephalopathic and unable to make decisions. He has been diagnosed with bacterial/aspiration PNA. He was receiving antibiotics initially. His daughters decided after multiple discussions about his poor prognosis to pursue comfort care including hospice placement and no surgery. They also asked for comfort feeds and to discontinue antibiotics. "
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Narrative:  Sxs are still present. Advised it may be SIRVA- shoulder injury related to vaccine administration.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Autoimmune hepatitis, Biopsy liver abnormal, Cholestatic liver injury, Hepatocellular injury
Clinical narrative: Narrative: Patient with acute severe hepatocellular and cholestatic liver injury. Liver biopsy suggestive of autoimmune hepatitis pattern. Patient with no known medical comorbidities prior to vaccination. No autoimmune disease history and previously healthy.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood albumin normal, Blood alkaline phosphatase normal, Blood calcium normal
Clinical narrative: Narrative: Pt reported blotchy red rash on upper extremities, hand shaking, sweating, and feeling of heart racing (HR 155) approximately 15 minutes after receiving first dose of Moderna COVID-19 vaccine. No SOB, throat swelling, itching. Reported some chest tightness but no pain. Symptoms resolved without treatment.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood magnesium normal, Blood potassium normal
Clinical narrative: Narrative: Pt reported blotchy red rash on upper extremities, hand shaking, sweating, and feeling of heart racing (HR 155) approximately 15 minutes after receiving first dose of Moderna COVID-19 vaccine. No SOB, throat swelling, itching. Reported some chest tightness but no pain. Symptoms resolved without treatment.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium normal, Blood thyroid stimulating hormone decreased, Carbon dioxide normal, Chest discomfort, Electrocardiogram normal
Clinical narrative: Narrative: Pt reported blotchy red rash on upper extremities, hand shaking, sweating, and feeling of heart racing (HR 155) approximately 15 minutes after receiving first dose of Moderna COVID-19 vaccine. No SOB, throat swelling, itching. Reported some chest tightness but no pain. Symptoms resolved without treatment.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Globulin, Glomerular filtration rate, Haematocrit normal, Haemoglobin normal
Clinical narrative: Narrative: Pt reported blotchy red rash on upper extremities, hand shaking, sweating, and feeling of heart racing (HR 155) approximately 15 minutes after receiving first dose of Moderna COVID-19 vaccine. No SOB, throat swelling, itching. Reported some chest tightness but no pain. Symptoms resolved without treatment.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Laboratory test, Lymphocyte count increased, Neutrophil count increased, Palpitations
Clinical narrative: Narrative: Pt reported blotchy red rash on upper extremities, hand shaking, sweating, and feeling of heart racing (HR 155) approximately 15 minutes after receiving first dose of Moderna COVID-19 vaccine. No SOB, throat swelling, itching. Reported some chest tightness but no pain. Symptoms resolved without treatment.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count normal, Rash, Rash erythematous, Rash macular, Tremor
Clinical narrative: Narrative: Pt reported blotchy red rash on upper extremities, hand shaking, sweating, and feeling of heart racing (HR 155) approximately 15 minutes after receiving first dose of Moderna COVID-19 vaccine. No SOB, throat swelling, itching. Reported some chest tightness but no pain. Symptoms resolved without treatment.